ArticleGut2026

Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapy.

Mar Iglesias Coma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.